Invention Grant
- Patent Title: Substituted benzothiophenyl derivatives as GPR40 agonists for the treatment of type II diabetes
-
Application No.: US16174378Application Date: 2018-10-30
-
Publication No.: US10662170B2Publication Date: 2020-05-26
- Inventor: Hui Huang , Gee-Hong Kuo , Mark R. Player , Shyh-Ming Yang , Yue-Mei Zhang
- Applicant: Janssen Pharmaceutica NV
- Applicant Address: BE Beerse
- Assignee: Janssen Pharmaceutica NV
- Current Assignee: Janssen Pharmaceutica NV
- Current Assignee Address: BE Beerse
- Main IPC: C07D409/10
- IPC: C07D409/10 ; C07D409/12 ; C07D333/54 ; C07D233/56 ; C07D409/02 ; C07D333/56 ; C07D409/04 ; C07D409/14 ; C07D495/10 ; A61K31/381 ; A61K31/4436
Abstract:
Disclosed are compounds, compositions and methods for treating of disorders that are affected by the modulation of the GPR40 receptor. Such compounds are represented by Formula (I) as follows: wherein R1, R2, R3, R5, R6, W, and A are defined herein.
Public/Granted literature
- US20190062300A1 SUBSTITUTED BENZOTHIOPHENYL DERIVATIVES AS GPR40 AGONISTS FOR THE TREATMENT OF TYPE II DIABETES Public/Granted day:2019-02-28
Information query
